Royalty Pharma (RPRX)
NASDAQ: RPRX
· Real-Time Price · USD
32.51
-0.31 (-0.94%)
At close: May 01, 2025, 2:41 PM
Royalty Pharma Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RPRX stock have an median target of 45.5, with a low estimate of 28 and a high estimate of 51. The median target predicts an increase of 39.96% from the current stock price of 32.51.
Latest Analyst Insight Report
According to 4 stock analyst, the rating for Royalty Pharma is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
3.05B
from 2.26B
Increased by 34.8%
Revenue Next Year
3.22B
from 3.05B
Increased by 5.7%
EPS This Year
4.67
from 1.92
Increased by 143.2%
EPS Next Year
5.25
from 4.67
Increased by 12.4%